HC notice to health minister Nadda in AIIMS case

CPIL petition seeks CBI investigation into corruption cases unearthed by vigilance officer Chaturvedi

GN Bureau | February 25, 2015


#nadda   #aiims   #health   #ministry   #satish chaturvedi   #vigilance   #corruption  

In an interesting development, Delhi high court has issued a notice to health minister J P Nadda, in a public interest litigation case filed by Centre for public interest and litigation. The CPIL has prayed to the court to initiate enquiry in all the cases by the CBI which were started during the tenure of Sanjiv Chaturvedi as CVO of All India institute of Medical sciences (AIIMS).

A bench of chief justice G Rohini and justice R S Endlaw issued notice to CBI and Sanjiv Chaturvedi as well. The high court will further hear the matter on April 2.

The CPIL has brought to the notice several irregularities like supply of dubious medicines and severe corruption in purchase of surgery equipments fake propriety certificate, exam process, unauthorized foreign visits of senior faculty members, accepting hospitality from private medical colleges in violation of MCI Regulations, middlemen in making OPD cards in AIIMS. 

The CPIL has pointed out that a new vigilance administration was shown the door for taking action against corrupt elements involved in rampant corruption in AIIMS. It is on record that in two years of tenure of Chaturvedi was extraordinary and a record number of cases were taken up from July, 2012 to August, 2014.

The CPIL petition says that Nadda while being a member of parliament wrote four letters between May, 2013 to June, 2014 to dismantle the new vigilance setup but it thoroughly rejected by then Union Health Secretary on 23.05.2014.  But after the regime change when BJP Came to power the same request were accepted in August, 2014.

The CPIL has requested the court to initiate CBI investigation into 37 cases of irregularities, illegalities and corruption in AIIMS and demanded the court to direct Nadda to recuse from all the cases mentioned in para no. 15 of the petition from acting as disciplinary authority/appellate authority.

Comments

 

Other News

Retail inflation crosses 6% mark

Retail inflation based on Consumer Price Index for October has reached 6.09%, whereas year-on-year food inflation, based on Consumer Food Price Index, for October is 8.94%, an official release said on Thursday.   Year-on-year inflation rate based on All India Consumer Price I

Cabinet approves museum at North-South Block complex

The Cabinet Committee on Economic Affairs, chaired by prime minister Narendra Modi, on Wednesday has approved the development of the Yuge Yugeen Bharat Museum (YYBM) at the North and South Block Complex, New Delhi, at an estimated total project cost of ₹3,230 crore, as appraised by the Public Investmen

Cabinet approves extension of Noida metro corridor

The Union Cabinet, chaired by prime minister Narendra Modi, has approved the extension of Aqua Line Metro Rail Corridor from Noida Sector-51 to Greater Noida Sector-04 of Noida Metro Rail Project with corridor for a length of 8.449 km with 5 elevated stations. On operationalization of this corridor, Noid

India reaffirms commitment to climate multilateralism

India has reaffirmed its commitment to climate multilateralism and the principles of Equity and Common But Differentiated Responsibilities and Respective Capabilities (CBDR-RC), calling for a fair, equitable and ambitious outcome at the 31st Conference of the Parties (COP31) to the United Nations Framewo

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter